These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27272255)

  • 21. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
    Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
    Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
    Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
    Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis.
    Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J
    Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review.
    Xiong X; Lin XK; Xiao X; Qin DP; Zhou DY; Hu JG; Liu Y; Zhong XS
    Nephrology (Carlton); 2016 Jan; 21(1):5-12. PubMed ID: 26072975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.
    Xu X; Xie Y; Lin Y; Xu X; Zhu Y; Mao Y; Hu Z; Wu J; Chen H; Zheng X; Qin J; Xie L
    Exp Ther Med; 2012 Dec; 4(6):1127-1133. PubMed ID: 23226787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector.
    Ding Z; Pan JQ
    Ann Hematol; 2005 Mar; 84(3):183-7. PubMed ID: 15309528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.
    Nikolopoulos GK; Bagos PG; Tsangaris I; Tsiara CG; Kopterides P; Vaiopoulos A; Kapsimali V; Bonovas S; Tsantes AE
    Clin Chem Lab Med; 2014 Jul; 52(7):937-50. PubMed ID: 24695040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.
    Zhao L; Bracken MB; Dewan AT; Chen S
    Mol Hum Reprod; 2013 Mar; 19(3):136-43. PubMed ID: 23180602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.
    Zhang H; Dong P; Yang X; Liu Z
    Int J Clin Exp Med; 2014; 7(10):3777-88. PubMed ID: 25419432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
    Doggen CJ; Bertina RM; Cats VM; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R; España F; Vázquez C; Fuster C; Almenar SM; Aznar J; Estellés A
    Thromb Res; 2006; 117(5):487-92. PubMed ID: 15907980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis.
    Sobhan MR; Mahdinezhad-Yazdi M; Moghimi M; Aghili K; Jafari M; Zare-Shehneh M; Neamatzadeh H
    Arch Bone Jt Surg; 2018 Nov; 6(6):468-477. PubMed ID: 30637301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction.
    Rallidis LS; Gialeraki A; Merkouri E; Liakos G; Dagres N; Sionis D; Travlou A; Lekakis J; Kremastinos DT
    J Thromb Thrombolysis; 2010 May; 29(4):497-502. PubMed ID: 19844663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
    Bae SC; Lee YH
    Z Rheumatol; 2020 Apr; 79(3):312-318. PubMed ID: 31428858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.